跳至主要内容
临床试验/IRCT201203049198N2
IRCT201203049198N2已完成未知

Comparison of efficacy of topical clobetasol 0.05% plus 5FU 5% cream vs. topical clobetasol 0.05% alone in the treatment of vitiligo.

Isfahan Univercity of Medical Sciences0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 65 years(—)
性别
All

入选标准

  • Inclusion criteria were as follow: vitiligo patients with at least 2 lesions on the body, >15 years old, lack of follicular pigmentation (score=0), lack of white hair over the lesion and disease stability within the last 6 months.
  • Exclusion criteria were as follow: those who had recieved topical medication for at least 1 month and systemic medication or phototherapy for at least 3 months prior to inclusion; past medical history of liver, kidney and hematologic disorders; the vitiligo lesions on the face, genitalia or acral areas; pregnancy or lactation and the segmental subtype. Patients were instructed about the study protocol, possible side effects and a written informed consent was taken from all patients before enrollment.

排除标准

  • 未提供

研究者

发起方
Isfahan Univercity of Medical Sciences

相似试验